THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0. A total of 20 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $286,000 | -77.2% | 308,000 | -76.5% | 0.01% | -72.4% |
| Q1 2022 | $1,254,000 | -0.4% | 1,308,000 | 0.0% | 0.03% | +16.0% |
| Q4 2021 | $1,259,000 | +17.0% | 1,308,000 | +13.1% | 0.02% | +8.7% |
| Q3 2021 | $1,076,000 | +627.0% | 1,157,000 | +636.9% | 0.02% | +666.7% |
| Q2 2021 | $148,000 | +45.1% | 157,000 | +57.0% | 0.00% | +50.0% |
| Q1 2021 | $102,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 13,473,000 | $12,756,000 | 1.74% |
| Shaolin Capital Management LLC | 14,065,000 | $13,281,000 | 0.93% |
| ZAZOVE ASSOCIATES LLC | 3,773,000 | $3,584,000 | 0.44% |
| FARALLON CAPITAL MANAGEMENT LLC | 56,695,000 | $53,806,000 | 0.32% |
| Baupost Group | 30,000,000 | $28,396,000 | 0.26% |
| Aequim Alternative Investments LP | 3,000,000 | $2,840,000 | 0.21% |
| WOLVERINE ASSET MANAGEMENT LLC | 24,100,000 | $22,817,000 | 0.17% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,500,000 | $5,257,000 | 0.15% |
| SSI INVESTMENT MANAGEMENT LLC | 1,750,000 | $1,648,000 | 0.12% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 430,000 | $406,000 | 0.06% |